Do you want to read an article? Please log in or register.
PPP2R2C promotes aerobic glycolysis and mediates pemetrexed resistance in lung adenocarcinomas by upregulating TCP1-dependent protein folding of glycolytic enzymes
Lung Cancer
RECOMMENDED
Related content
Lung Cancer
Clinical Efficacy and Safety of Icotinib as Adjuvant Therapy for Resected Stage IA Lung Adenocarcinoma: A Real-world Study
Clin Lung Cancer
Luo SS, Zhong LQ, Liu X, Li SN, Zhang X, Ao Y, Yang H, Hu Y
doi: 10.1016/j.cllc.2026.07.006
Lung Cancer
Dexamethasone enhances cold atmospheric-pressure plasma-induced antitumor effects in lung adenocarcinoma partly through ROS-associated apoptosis and suppression of PI3K/AKT signaling
Sci Rep
Kong L, Sun T, Liu C, Sui S, Song W, Ni G
doi: 10.1038/s41598-026-53040-2
Lung Cancer
Club cell secretory protein (CCSP) serum concentration is a prognostic factor after surgical resection of localized non-small cell lung cancer in patients in the IFCT-0302 trial
Lung Cancer
Brosseau S, Etienne H, Peoc'h K, Langlais A, Blanché H, Foucher P, Barlesi F, Domas J, Girard P, Scherpereel A, Dumont P, Derollez M, Quoix E, Debieuvre D, Deleuze JF, Leçon-Malas V, Zalcman G, Westeel V, Mordant P
doi: 10.1016/j.lungcan.2026.109345
Lung Cancer
Pattern of brain metastases and survival in lung adenocarcinoma with KRAS or EFGR mutation
Lung Cancer
Faehling M, Fallscheer S, Schmiederer J, Sträter J, Christopoulos P, Lengerke C, Seifarth H
doi: 10.1016/j.lungcan.2025.108803
Lung Cancer
Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study)
Lung Cancer
Hayasaka K, Shimokawa M, Haratake N, Notsuda H, Katsumata S, Hamada A, Nomura K, Fujino K, Yoshikawa M, Suzawa K, Shien K, Suda K, Ohara S, Fukuda S, Kinoshita I, Takamori S, Muto S, Takanashi Y, Mizuno K, Hayakawa T, Sekihara K, Toda M, Matsuo S, Takegahara K, Hashimoto M, Nakahashi K, Endo M, Ozawa H, Fujikawa R, Tomioka Y, Namba K, Matsubara T, Suzuki J, Watanabe H, Takada K, Hoshino H, Kaiho T, Toyoda T, Shiono S, Soh J, Ohde Y, Okada Y
doi: 10.1016/j.lungcan.2026.108908
Further Publications
International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition
J Heart Lung Transplant
Calabrese F, Levine DJ, Adam BA, Agbor-Enoh S, Benden C, Budev MM, Cochrane AB, Cozzi E, Darley DR, Fishbein GA, Gelman AE, Glanville AR, Greenland JR, Hickey MJ, Ius F, Jaksch P, Jackson AM, Joerns JO, Lor H, Lowery EM, Mangiola M, Morlacchi LC, Murray MA, Nair A, Ocagli H, Parmar JS, Pavlisko EN, Perch M, Rahaghi FF, Roden AC, Roux A, Snyder L, Sweet S, Verleden SE, Visner GA, Vos R, Wikenheiser-Brokamp KA, Zeevi A, Hachem RR
doi: 10.1016/j.healun.2026.04.019
Lung Cancer
Systematic review and network meta-analysis: evaluation of systemic therapies for platinum refractory or resistant small cell lung cancer
Lung Cancer
Desai RK, Zhou EJ, Chan KKW
doi: 10.1016/j.lungcan.2025.108812
Lung Cancer
Final overall survival analysis of the APPLE study: atezolizumab and platinum-pemetrexed with or without bevacizumab for metastatic nonsquamous non-small cell lung cancer
Lung Cancer
Shiraishi Y, Kishimoto J, Sugawara S, Mizutani H, Daga H, Azuma K, Matsumoto H, Hataji O, Nishino K, Mori M, Shukuya T, Saito H, Tachihara M, Tanaka K, Tsuya A, Wakuda K, Yanagitani N, Sakamoto T, Baba J, Hata A, Okada M, Kozuki T, Sato Y, Takahata Y, Yamada T, Yamamoto N, Nakagawa K, Okamoto I
doi: 10.1016/j.lungcan.2026.109447
RECOMMENDED
Lung Cancer
Impact of First-Line Maintenance Immunotherapy With or Without Pemetrexed for Non-Squamous Advanced/Metastatic Non-Small Cell Lung Cancer Lacking Targetable Mutations: A Real-World Analysis in England
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
Clin Lung Cancer
Gomes F, Gilding N, Tan V, Christoforou K, Rule J, Aziez A, Januszewski A, Minchom A
doi: 10.1016/j.cllc.2025.12.007